Redmile Group, LLC, 10% Owner at ADC Therapeutics SA (ADCT), bought 1,467,492 shares on 2024-01-05, disclosed to the SEC on 2024-02-09.
Open-market purchase of $0 ADCT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 56,900 | $0 | NaN% |
| 2 | $0.00 | 28,652 | $0 | NaN% |
| 3 | $0.00 | 50,000 | $0 | NaN% |
| 4 | $0.00 | 100,000 | $0 | NaN% |
| 5 | $0.00 | 100,000 | $0 | NaN% |
| 6 | $0.00 | 100,000 |
| $0 |
| NaN% |
| 7 | $0.00 | 100,000 | $0 | NaN% |
| 8 | $0.00 | 93,424 | $0 | NaN% |
| 9 | $0.00 | 53,900 | $0 | NaN% |
| 10 | $0.00 | 50,000 | $0 | NaN% |
| 11 | $0.00 | 100,000 | $0 | NaN% |
| 12 | $0.00 | 100,000 | $0 | NaN% |
| 13 | $0.00 | 150,000 | $0 | NaN% |
| 14 | $0.00 | 100,000 | $0 | NaN% |
| 15 | $0.00 | 150,000 | $0 | NaN% |
| 16 | $0.00 | 15,867 | $0 | NaN% |
| 17 | $0.00 | 11,159 | $0 | NaN% |
| 18 | $0.00 | 107,590 | $0 | NaN% |
| Total | $0.00 avg | 1,467,492 | $0 | 100% |
| Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |
| ZYME | BUY | 2022-10-18 | $153K | — | Filing → |